← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksXYLAnalysis
OverviewAnalysisPriceRevenueEarningsP/ERatiosDividendTargets
Analysis OverviewHoldUpdated May 1, 2026

XYL logoXylem Inc. (XYL) Stock Analysis

Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.

Analyst consensus
Hold
Covering
40
analysts
18 bullish · 1 bearish · 40 covering XYL
Strong Buy
0
Buy
18
Hold
21
Sell
1
Strong Sell
0
Consensus Target
$152
+27.8% vs today
Scenario Range
$69 – $181
Model bear to bull value window
Coverage
40
Published analyst ratings
Valuation Context
21.4x
Forward P/E · Market cap $28.2B

Decision Summary

Xylem Inc. (XYL) is rated Hold by Wall Street. 18 of 40 analysts are bullish, with a consensus target of $152 versus a current price of $118.59. That implies +27.8% upside, while the model valuation range spans $69 to $181.

Note: Strong analyst support doesn't guarantee returns. At 21.4x forward earnings, much of the optimism may already be priced in. Use the scenario range to judge whether the upside justifies the risk.
Upside case
Street consensus points to +27.8% upside. The bull scenario stretches to +52.6% if XYL re-rates higher.
Downside frame
The bear case maps to $69 — a -41.7% drop — if investor confidence compresses the multiple sharply.

XYL price targets

Three scenarios for where XYL stock could go

Current
~$119
Confidence
67 / 100
Updated
May 1, 2026
Where we are now
you are here · $119
Bear · $69
Base · $166
Bull · $181
Current · $119
Bear
$69
Base
$166
Bull
$181
Upside case

Bull case

$181+52.6%

XYL would need investors to value it at roughly 33x earnings — about 11x more generous than today's 21x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.

Market caseClosest to today

Base case

$166+39.7%

At 30x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.

Stress case

Bear case

$69-41.7%

If investor confidence fades or macro conditions deteriorate, a 9x multiple contraction could push XYL down roughly 42% from where it trades now.

Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

XYL logo

Xylem Inc.

XYL · NYSEIndustrialsIndustrial - MachineryDecember year-end
Data as of May 1, 2026

Xylem is a global water technology company that designs, manufactures, and services engineered products and solutions for water and wastewater applications. It generates revenue through three main segments: Water Infrastructure (~45% of sales), Applied Water (~35%), and Measurement & Control Solutions (~20%), selling pumps, treatment equipment, smart meters, and related services. The company's competitive advantage lies in its comprehensive portfolio of trusted brands—Flygt, Godwin, Goulds, and others—and deep technical expertise across the entire water cycle, creating high switching costs for utilities and industrial customers.

Market Cap
$28.2B
Revenue TTM
$9.1B
Net Income TTM
$973M
Net Margin
10.7%

XYL Revenue and Earnings Performance

Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.

EPS Beat Rate
92%Exceptional
12 quarters tracked
Revenue Beat Rate
92%Exceptional
vs consensus estimates
Avg EPS Surprise
+6.5%
above Street consensus
Beat / Miss Record
BeatMissLeft = EPS · Right = Revenue
Q3 2025
Q4 2025
Q1 2026
Q2 2026

Last 4 Quarters

EPS beats: 4 of 4
Q3 2025
EPS
$1.26/$1.15
+9.6%
Revenue
$2.3B/$2.2B
+4.2%
Q4 2025
EPS
$1.37/$1.23
+11.4%
Revenue
$2.3B/$2.2B
+2.0%
Q1 2026
EPS
$1.42/$1.41
+0.7%
Revenue
$2.4B/$2.4B
+1.1%
Q2 2026
EPS
$1.12/$1.09
+2.8%
Revenue
$2.1B/$2.1B
+0.7%
QuarterEPS (Actual / Est)EPS SurpriseRevenue (Actual / Est)Rev Surprise
Q3 2025$1.26/$1.15+9.6%$2.3B/$2.2B+4.2%
Q4 2025$1.37/$1.23+11.4%$2.3B/$2.2B+2.0%
Q1 2026$1.42/$1.41+0.7%$2.4B/$2.4B+1.1%
Q2 2026$1.12/$1.09+2.8%$2.1B/$2.1B+0.7%
FY1–FY2 Estimates
Revenue Outlook
FY1
$9.7B
+6.5% YoY
FY2
$10.6B
+9.2% YoY
EPS Outlook
FY1
$5.02
+25.7% YoY
FY2
$5.47
+9.0% YoY
Trailing FCF (TTM)$966M
FCF Margin: 10.6%
Next Earnings
—
Expected EPS
—
Expected Revenue
—

XYL beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.

XYL Revenue Breakdown by Segment

Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.

Latest disclosure
FY 2025
Total disclosed revenue $6.6B

Product Mix

Latest annual revenue by segment or product family

Water Infrastructure
40.1%
+3.2% YoY

Tap, hover, or focus a slice to inspect segment detail.

SegmentYoYRevenueMix

Geographic Mix

Latest annual revenue by reported region

UNITED STATES
57.7%
+7.1% YoY

Tap, hover, or focus a slice to inspect segment detail.

SegmentYoYRevenueMix
Water Infrastructure is the largest disclosed segment at 40.1% of FY 2025 revenue, up 3.2% YoY.
UNITED STATES is the largest reported region at 57.7%, up 7.1% YoY.
See full revenue history

XYL Valuation Snapshot

Current multiples compared to the S&P 500, the company's sector, and its own five-year average.

Relative Value Signal
Fairly Valued

Fair value est. $115 — implies -0.0% from today's price.

Premium to Fair Value
0.0%
above fair value
Deep DiscountFair ValueVery Expensive
vs S&P 500 Trailing P/E
XYL
30.3x
vs
S&P 500
25.2x
+20% premium
vs Industrials Trailing P/E
XYL
30.3x
vs
Industrials
25.9x
+17% premium
vs XYL 5Y Avg P/E
Today
30.3x
vs
5Y Average
43.0x
30% discount
Forward PE
21.4x
S&P 500
19.1x
+12%
Industrials
20.8x
+3%
5Y Avg
—
—
Trailing PE
30.3x
S&P 500
25.2x
+20%
Industrials
25.9x
+17%
5Y Avg
43.0x
-30%
PEG Ratio
1.32x
S&P 500
1.75x
-24%
Industrials
1.59x
-17%
5Y Avg
—
—
EV/EBITDA
15.9x
S&P 500
15.3x
+4%
Industrials
13.9x
+15%
5Y Avg
22.7x
-30%
Price/FCF
31.0x
S&P 500
21.3x
+45%
Industrials
20.6x
+50%
5Y Avg
45.6x
-32%
Price/Sales
3.1x
S&P 500
3.1x
-0%
Industrials
1.6x
+96%
5Y Avg
3.6x
-14%
Dividend Yield
1.35%
S&P 500
1.88%
-28%
Industrials
1.24%
+9%
5Y Avg
1.13%
+20%
MetricXYLS&P 500· delta vs XYLIndustrials5Y Avg XYL
Forward PE21.4x
19.1x+12%
20.8x
—
Trailing PE30.3x
25.2x+20%
25.9x+17%
43.0x-30%
PEG Ratio1.32x
1.75x-24%
1.59x-17%
—
EV/EBITDA15.9x
15.3x
13.9x+15%
22.7x-30%
Price/FCF31.0x
21.3x+45%
20.6x+50%
45.6x-32%
Price/Sales3.1x
3.1x
1.6x+96%
3.6x-14%
Dividend Yield1.35%
1.88%
1.24%
1.13%
XYL trades above S&P 500 benchmarks on 3 of 6 measured multiples — is elevated on some multiples, but competitive on others — a mixed valuation picture.

Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.

Open valuation tool

XYL Financial Health

Verdict
Strong

XYL generates $966M in free cash flow at a 10.6% margin — returns 1.4% of market cap to shareholders annually.

Cash Engine

Revenue, margins, and cash generation

Revenue (TTM)
Trailing-twelve-month sales base
$9.1B
Revenue Growth
TTM vs prior year
+5.7%
Gross Margin
Gross profit as a share of revenue
38.6%
Operating Margin
Operating income divided by revenue
13.6%
Net Margin
Net income divided by revenue
10.7%
EPS (TTM)
Diluted earnings per share, trailing twelve months
$4.00
Free Cash Flow (TTM)
Cash generation after capex
$966M
FCF Margin
FCF as share of revenue — the primary cash quality signal
10.6%

Capital Quality

ROIC, leverage, and debt serviceability

ROIC
Return on invested capital — primary competitive quality signal
7.6%
ROA
Return on assets, trailing twelve months
5.6%
Cash & Equivalents
Liquid assets on the balance sheet
$1.5B
Net Debt
Total debt minus cash
$463M
Debt Serviceability
Net debt as a multiple of annual free cash flow
0.5× FCF

~0.5 years to full repayment at current FCF run-rate

ROE
Return on equity, trailing twelve months
8.5%

Shareholder Returns

How capital is returned to owners

Total shareholder yield
1.4%
Dividend
1.4%
Buyback
0.1%
Share Repurchases
Trailing buyback outflow — dollar magnitude of capital returned
$15M
Dividend / Share
Annualized trailing dividend per share
$1.60
Payout Ratio
Share of earnings distributed as dividends
40.9%
Shares Outstanding
Declining as buybacks retire shares
238M

All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).

Open full ratios page

XYL Stock Risk Factors

Key factors that could pressure the stock price, compress the multiple, or weigh on future results.

AI analysis · updated April 11, 2026

01
High Risk

Valuation Premium Risk

Xylem’s shares may be trading at a premium relative to peers, leaving little margin for error if earnings or revenue miss expectations. A shortfall could trigger a sharp price correction, impacting shareholder returns.

02
High Risk

Liquidity Constraint

The company’s current ratio of 1.63 indicates that current assets barely cover short‑term liabilities, limiting financial flexibility. Tight liquidity could constrain working capital and ability to fund operations during downturns.

03
Medium

Acquisition Integration Risk

Evoqua and the planned Idrica acquisition carry integration challenges that could delay synergy realization. Failure to integrate effectively could erode projected revenue and margin gains.

04
Medium

Project Timing & Funding

Delays in government water infrastructure funding or the timing of large smart‑metering contracts can postpone revenue recognition. Such timing uncertainties may compress quarterly earnings.

05
Lower

Competitive Pricing Pressure

Competitors may undercut Xylem’s higher‑margin business, eroding market share and pressuring margins. Price wars could reduce profitability over the long term.

06
Lower

Strategic Shift Impact

The 80/20 profitability focus may slow short‑term revenue growth, creating a window for competitors to capture market share. Investors may see a temporary dip in top‑line growth.

These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.

Why XYL Stock Could Outperform

Structural drivers behind the upside case and why the stock could outperform over the next 12 months.

AI analysis · updated April 11, 2026

01

Profitability & Revenue Momentum

Xylem has posted year‑over‑year revenue growth and a solid net profit margin of 10.6%. The company reported record quarterly EBITDA margins and earnings per share, with expectations for continued earnings growth.

02

Strategic Acquisitions Fuel Growth

The acquisition of Evoqua is expected to significantly enhance Xylem's growth profile and operational performance, boosting margins. The company is also planning a majority stake in Idrica and has accelerated synergy targets related to the Evoqua integration.

03

Aggressive Shareholder Returns

In February 2026, Xylem approved a new share repurchase program authorizing up to $1.5 billion of its own stock. The program complements an 8% dividend increase, underscoring the company's commitment to returning capital to shareholders.

04

Digital Revenue Drives Margin Expansion

Xylem Vue digital revenue is targeting over 30% growth, contributing to recurring higher‑margin revenue. Integration benefits and digital expansion justify a premium valuation.

A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.

Price target page

XYL Stock Price Performance

52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.

Current Price
$118.59
52W Range Position
11%
52-Week Range
Current price plotted between the 52-week low and high.
11% through range
52-Week Low
$114.15
+3.9% from the low
52-Week High
$154.27
-23.1% from the high
1 Month
-4.25%
3 Month
-16.56%
YTD
-13.5%
1 Year
-1.5%
3Y CAGR
+3.4%
5Y CAGR
-0.0%
10Y CAGR
+11.0%

Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.

Full price historyP/E history

XYL vs Peers

Valuation, growth, and margin comparison against the closest publicly traded peers for this company.

Peer Set
Accurate peer set
Forward PE
21.4x
vs 20.7x median
+3% above peer median
Revenue Growth
+6.5%
vs +2.4% median
+177% above peer median
Net Margin
10.7%
vs 10.8% median
-1% below peer median
CompanyMkt CapFwd PERev GrwMarginRatingUpside
XYL
XYL
Xylem Inc.
$28.2B21.4x+6.5%10.7%Hold+27.8%
PNR
PNR
Pentair plc
$12.9B14.9x+2.4%16.0%Hold+42.0%
FEL
FELE
Franklin Electric Co., Inc.
$4.5B22.0x+5.0%6.9%Hold-1.0%
GFF
GFF
Griffon Corporation
$4.3B17.7x-5.2%1.8%Buy+20.4%
DHR
DHR
Danaher Corporation
$123.8B20.7x+1.8%14.9%Buy+41.2%
ITT
ITT
ITT Inc.
$19.4B28.3x+14.2%10.8%Buy+6.0%

This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.

XYL Dividend and Capital Return

XYL returns 1.4% total yield, led by a 1.35% dividend, raised 15 consecutive years.

Dividend SustainableFCF Well Covered
Total Shareholder Yield
1.4%
Dividend + buyback return per year
Buyback Yield
0.1%
Dividend Yield
1.35%
Payout Ratio
40.9%
How XYL Splits Its Return
Div 1.35%
Dividend 1.35%Buybacks 0.1%

Dividend Profile

Yield, cadence, and growth quality

Dividend / Share
Trailing annualized cash dividend
$1.60
Growth Streak
Consecutive years of dividend increases
15Y
3Y Div CAGR
10.1%
5Y Div CAGR
9.0%
Ex-Dividend Date
—
Payment Cadence
Quarterly
4 payments over the last 12 months

Buyback Engine

How much per-share support comes from repurchases

Repurchases (TTM)
Cash used for buybacks in the latest trailing period
$15M
Estimated Shares Retired
126.5K
Approx. Share Reduction
0.1%
Shares Outstanding
Current diluted share count from the screening snapshot
238M
YearDiv / ShareYoY GrwBB YieldTotal Yield
2026$0.43———
2025$1.60+11.1%0.0%1.2%
2024$1.44+9.1%0.1%1.3%
2023$1.32+10.0%0.1%1.3%
2022$1.20+7.1%0.3%1.3%
Full dividend history
FAQ

XYL Investor Questions

Common questions answered from live analyst data and company financials.

7 questions
01

Is Xylem Inc. (XYL) stock a buy or sell in 2026?

Xylem Inc. (XYL) is rated Hold by Wall Street analysts as of 2026. Of 40 analysts covering the stock, 18 rate it Buy or Strong Buy, 21 rate it Hold, and 1 rate it Sell or Strong Sell. The consensus 12-month price target is $152, implying +27.8% from the current price of $119. The bear case scenario is $69 and the bull case is $181.

02

What is the XYL stock price target for 2026?

The Wall Street consensus price target for XYL is $152 based on 40 analyst estimates. The high-end target is $161 (+35.8% from today), and the low-end target is $133 (+12.2%). The base case model target is $166.

03

Is Xylem Inc. (XYL) stock overvalued in 2026?

XYL trades at 21.4x times forward earnings. The stock trades at a notable premium to the broad market, which is typical for businesses with strong free cash flow and above-average growth expectations. Based on current multiples versus the peer group, the relative model signals fairly valued. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.

04

What are the main risks for Xylem Inc. (XYL) stock in 2026?

The primary risks for XYL in 2026 are: (1) Valuation Premium Risk — Xylem’s shares may be trading at a premium relative to peers, leaving little margin for error if earnings or revenue miss expectations. (2) Liquidity Constraint — The company’s current ratio of 1. (3) Acquisition Integration Risk — Evoqua and the planned Idrica acquisition carry integration challenges that could delay synergy realization. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.

05

What is Xylem Inc.'s revenue and earnings forecast?

Analyst consensus estimates XYL will report consensus revenue of $9.7B (+6.5% year-over-year) and EPS of $5.02 (+25.7% year-over-year) for the upcoming fiscal year. The following year, analysts project $10.6B in revenue.

06

When does Xylem Inc. (XYL) report its next earnings?

A confirmed upcoming earnings date for XYL is not yet available. Check the Earnings section above for the most recent quarterly report dates and forward estimates.

07

How much free cash flow does Xylem Inc. generate?

Xylem Inc. (XYL) generated $966M in free cash flow over the trailing twelve months — a free cash flow margin of 10.6%. XYL returns capital to shareholders through dividends (1.4% yield) and share repurchases ($15M TTM).

Continue Your Research

Xylem Inc. Stock Overview

Price chart, key metrics, financial statements, and peers

XYL Valuation Tool

Is XYL cheap or expensive right now?

Compare XYL vs PNR

Side-by-side financials, valuation, and ratings

Deep Dive Analysis

XYL Price Target & Analyst RatingsXYL Earnings HistoryXYL Revenue HistoryXYL Price HistoryXYL P/E Ratio HistoryXYL Dividend HistoryXYL Financial Ratios

Related Analysis

Pentair plc (PNR) Stock AnalysisFranklin Electric Co., Inc. (FELE) Stock AnalysisGriffon Corporation (GFF) Stock AnalysisCompare XYL vs FELES&P 500 Mega Cap Technology Stocks
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.